The Prevention and Management of Contrast-induced Acute Kidney Injury: A Mini-review of the Literature

被引:22
作者
Ali, Asad [1 ,2 ]
Bhan, Chandur [3 ]
Malik, Muhammad Bilal [4 ]
Ahmad, Malik Qistas [5 ]
Sami, Shahzad Ahmed. [6 ]
机构
[1] CMH Lahore Med Coll, Med, Lahore, Pakistan
[2] Inst Dent, Lahore, Pakistan
[3] Chandka Med Coll Hosp, Internal Med, Larkana, Pakistan
[4] Shifa Coll Med, Internal Med, Islamabad, Pakistan
[5] Univ Arizona, Canc Ctr, Hematol Oncol, Tucson, AZ 85721 USA
[6] CMH Med & Dent Coll, Internal Med, Lahore, Pakistan
来源
CUREUS | 2018年 / 10卷 / 09期
关键词
nephropathy; acute tubular necrosis; pharmacologic treatment; nephrotoxicity; contrast induced nephropathy; hemodialysis; radiological; volume expansion; acute kidney injury; nephroprotective;
D O I
10.7759/cureus.3284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Contrast-induced acute kidney injury, also called contrast-induced nephropathy, is one of the main causes of acute renal failure/ acute kidney injury (AKI) in hospitalized patients within 48 to 72 hours of contrast media administration during various radiologic procedures. Several factors can be responsible for contrast-induced acute tubular necrosis (ATN); however, patient and procedure-related factors play the lead role in determining the development of contrastinduced nephropathy. There is no definitive treatment and hydration remains the mainstay preventive strategy. This article will review the incidence, criteria for definitive diagnosis, and an effective approach on how to prevent contrast-induced nephropathy in a clinical setup.
引用
收藏
页数:6
相关论文
共 48 条
[1]  
Andreucci M, 2014, ADV NEPHROL, V2014, P11, DOI DOI 10.1155/2014/691623
[2]   Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention [J].
Andreucci, Michele ;
Solomon, Richard ;
Tasanarong, Adis .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[3]   Angiotensinogen as a biomarker of acute kidney injury [J].
Aqeel, Sheeba Habeeb Ba ;
Sanchez, Alejandro ;
Batlle, Daniel .
CLINICAL KIDNEY JOURNAL, 2017, 10 (06) :759-768
[4]   Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies [J].
Azzalini, Lorenzo ;
Spagnoli, Vincent ;
Ly, Hung Q. .
CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (02) :247-255
[5]   Theophylline for prevention of contrast-induced nephropathy - A systematic review and meta-analysis [J].
Bagshaw, SM ;
Ghali, WA .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1087-1093
[6]   The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials [J].
Barbieri, Lucia ;
Verdoia, Monica ;
Schaffer, Alon ;
Nardin, Matteo ;
Marino, Paolo ;
De Luca, Giuseppe .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (04) :493-502
[7]   Effectiveness of Theophylline in Preventing Contrast-Induced Nephropathy After Coronary Angiographic Procedures [J].
Bilasy, Mohammed Elshawadfy M. ;
Oraby, Mohammed A. ;
Ismail, Hussein M. ;
Maklady, Fathi A. .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2012, 25 (04) :404-410
[8]   Contrast-induced nephropathy: Protective role of fenoldopam [J].
Caixeta, Adriano ;
Dogan, Ozgen ;
Weisz, Giora .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2012, 39 (06) :497-505
[9]   The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: A comparison with periprocedural hemofiltration [J].
Choi, Myung-Jin ;
Yoon, Jong-Woo ;
Han, Sang-Jin ;
Choi, Hyun-Hee ;
Song, Young-Rim ;
Kim, Sung-Gyun ;
Oh, Ji-Eun ;
Lee, Young-Ki ;
Seo, Jang-Won ;
Kim, Hyung-Jik ;
Noh, Jung-Woo ;
Koo, Ja-Ryong .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) :941-945
[10]   FOSCARNET NEPHROTOXICITY - MECHANISM, INCIDENCE AND PREVENTION [J].
DERAY, G ;
MARTINEZ, F ;
KATLAMA, C ;
LEVALTIER, B ;
BEAUFILS, H ;
DANIS, M ;
ROZENHEIM, M ;
BAUMELOU, A ;
DOHIN, E ;
GENTILINI, M ;
JACOBS, C .
AMERICAN JOURNAL OF NEPHROLOGY, 1989, 9 (04) :316-321